The MOL (Musculoskeletal Oncology Lab) at the University of Pittsburgh researches the biology of primary and metastatic musculoskeletal tumors. They help develop treatments for individuals with metastatic sarcoma and breast cancer bone metastases, particularly for patients at UPMC.
In 2010, MOL established a musculoskeletal oncology tumor registry and tissue bank. Years of time-stamped patient clinical data and tissue samples, collected over the entire course of disease and treatment, now provide evidence of disease progress and the effects of treatment.
The substantial volume of patients and the variety of disease manifestations treated at the UPMC Hillman Cancer Institute–combined with the research infrastructure at the University of Pittsburgh–make the library a unique resource for translational research. These patient clinical data and tissue samples provide a powerful research resource that is not obtainable elsewhere.
Challenge – Need to Track Clinical Information and Samples Together
Solution – Safe, Reliable, Synchronized Tracking of Patient Clinical Data and Biospecimens in Biobank
Result – eLabJournal Ties Biospecimens and Data Together for Totally Reliable Biobank Operation
Our lab has established a biobank for over 40 subtypes of sarcoma. We needed a better way to track our biospecimen inventory. eLab allowed us to store clinical information on the same platform where the biospecimen inventory was logged.
We used to use separate Excel spreadsheets to track inventory and clinical information, which was tedious and time consuming. eLab has provided a secure platform that is able to grow and adapt with our ever evolving biobank.
– Tanya Heim, Clinical Research Coordinator